|
EVT
|
Evotec SE
|
0.61%
|
DE
|
XETRA
|
|
QURE
|
uniQure N.V.
|
0.60%
|
US
|
NASDAQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
0.59%
|
US
|
NASDAQ
|
|
ARCT
|
Arcturus Therapeutics Ltd.
|
0.58%
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
0.56%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
0.56%
|
US
|
NASDAQ
|
|
AMRS
|
Amyris, Inc.
|
0.55%
|
US
|
NASDAQ
|
|
VCEL
|
Vericel Corporation
|
0.53%
|
US
|
NASDAQ
|
|
STOK
|
Stoke Therapeutics, Inc.
|
0.51%
|
US
|
NASDAQ
|
|
NTRA
|
Natera, Inc.
|
0.50%
|
US
|
NASDAQ
|
|
PACB
|
Pacific Biosciences of California, Inc.
|
0.49%
|
US
|
NASDAQ
|
|
NEO
|
NeoGenomics, Inc.
|
0.49%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
0.46%
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
0.45%
|
US
|
NASDAQ
|
|
TXG
|
10x Genomics, Inc.
|
0.45%
|
US
|
NASDAQ
|
|
SGMO
|
Sangamo BioSciences, Inc.
|
0.44%
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
0.43%
|
US
|
NASDAQ
|
|
CVAC
|
CureVac N.V.
|
0.36%
|
US
|
NASDAQ
|
|
CDXS
|
Codexis, Inc.
|
0.33%
|
US
|
NASDAQ
|
|
CE2
|
CropEnergies AG
|
0.32%
|
DE
|
XETRA
|